Smash Notes

Back to Thrive Capital's Bet on Neuralink, OpenAI & the Future of Medicine, with Nworah Ayogu.

How Does Neuralink Give Paralyzed People Function Back?

Nworah Ayogu said healthcare often does a very good job of extending life and does not do a very good job of improving quality of life or giving people life back. Neuralink created an implantable device so people can interact with the world again. The device lets them control a computer with their minds. Motorized arms let them control a robotic arm to pick things and grab things. In another trial, Neuralink implanted the device in the vocal cortex so someone who was not able to speak could speak.

Neuralink now focuses on a lot of populations. One of the first was people with ALS or paralysis, whether through a disease or a car accident. A lot are veterans who served the country and no longer have usage of their arms and legs. Nworah Ayogu said they maybe were hit with an IED. Often they are young, 30 or 40, and no longer able to work, because work often needs hands and legs. They also cannot be outside playing with their children.

He said the core of Neuralink is using the implant so people can manipulate the outside world again. He added that Neuralink may not replace the arms and legs someone has lost, and states the implant can still give that functionality back.

Transcript

Thrive Capital's Bet on Neuralink, OpenAI & the Future of Medicine ·

Sourcery

More from this episode

  1. Why Is Drug Discovery Moving Faster Than Ever?Nworah Ayogu said that, more so than at maybe any other time in history, the frontier of science and the frontier of what has been accomplished is moving…
  2. What Do Drug Discovery Models Actually Get Right?Drug discovery models have gotten better and better at the first job: choosing a molecule that binds a chosen target well.
  3. Why Is Neuralink More Interesting Than SpaceX?Nworah Ayogu called Neuralink a more interesting company than SpaceX, because the brain is vaster than space. "A $3 trillion company?"
  4. How Did One Merck Drug Outearn Every Major Lab?Nworah Ayogu said Keytruda, one Merck drug, had 2025 revenue larger than the revenue of all the major labs combined. Biotech is already big business.
  5. How Did OpenEvidence Reach Two Thirds of Doctors?Nworah Ayogu said OpenEvidence spread because doctors wanted it. Nworah Ayogu said he had never heard doctors rave about a clinical tool.
  6. What Is the Price of One Child's Life?Nworah Ayogu said medicine can now treat rare genetic problems one patient at a time, and said a million and a half dollars to make and deliver a treatment is…
  7. How Did Oscar Health Recover From a 95 Percent Drop?Oscar Health, the first company Thrive ever invested in, fell 95% from its peak value in December 22. It then climbed back above its IPO price.

People

More answers like this

Related episodes

Plays from this note through the rest of the episode.

Weekly highlights

One letter a week.

The notes worth hearing, with the minute they were said.